Tentative title: Strengthening the Health System while Responding to the Ebola Virus Disease Epidemic: Lessons Learned by Partners In Health in Sierra Leone
Corrado Cancedda MD, PhD, Partners In Health, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA.
Corrado Cancedda, MD, PhD was trained in Internal Medicine and Infectious Disease. He is an Associate Physician at Brigham and Women's Hospital in the Division of Global Health Equity and practicing clinician within the Department of Medicine, and he is an Instructor and teacher of Global Health Delivery within the Department of Global Health and Social Medicine at Harvard Medical School. Dr. Cancedda has extensive expertise in curriculum development, global medical education, and academic partnerships. He worked four years in Rwanda as Chief of Medical Education and Director of the Department of Medical Education and Training for Partners In Health. During his tenure, Dr. Cancedda successfully lead the development and implementation of educational and in-service training programs aimed at Rwandan health professionals and leveraged the educational resources available at Harvard Medical School and Brigham and Women’s Hospital to improve the quality and increase the scope and diversity of such trainings. Working under the leadership of the Ministry of Health and in partnership with the Clinton Health Access Initiative, Dr. Cancedda contributed to the conceptualization, development, launch, and implementation of the Rwanda Human Resources for Health (HRH) Program. Lead by the MOH and supported by the United States Government, this ambitious initiative seeks to build the country’s health education infrastructure through the contributions of top North American universities and academic medical centers (AMCs) within a timeframe spanning from 2012 to 2018. These institutions will supply full-time specialist faculty and collaborate with each other and their Rwandan counterparts on all aspects of health professional education. Dr. Cancedda is the principal investigator for the contribution of Harvard Medical School and Harvard-affiliated hospitals to the Rwanda HRH Program. Dr. Cancedda’s interest lies in the establishment of mutually beneficial academic partnerships between universities and AMCs from the resource-rich world and from developing countries as a mean to address shared global health challenges and promote global health equity.
Title: Recent Progress in iPS Cell Research and Application
Shinya Yamanaka. Professor, Director of CiRA (Centre for iPS cell Research and Application), Kyoto University.
Shinya Yamanaka won the Nobel Prize in Physiology or Medicine 2012 ( along with Sir John B. Gurdon). Professor Yamanaka's award was for the discovery that mature cells can be reprogrammed to become pluripotent. Yamanaka is also a past president of the International Society for Stem Cell Research (ISSCR).
Professor Yamanaka's research group focuses on stem cell biology and developmental engineering. In particular, they have established mouse and human induced pluripotent stem cells (iPS cells), and are carrying out various aspects of basic and applied research using iPS cell technology.
Title: From Conception to the Clinic, Making Ideas Useful
Professor Jeffrey M Karp, Brigham & Women's Hospital, Harvard Medical School, Harvard-MIT Division of Health Sciences and Technology, Boston, USA.
Prof. Jeff Karp is a world leader in drug delivery, stem cell therapeutics, and tissue adhesives. He is an Associate Professor at Brigham and Women’s Hospital, Harvard Medical School, Principal Faculty at the Harvard Stem Cell Institute, and an affiliate faculty at the Broad Institute and at the Harvard-MIT Division of Health Sciences and Technology.
He has published >100 peer-reviewed papers (>10,500 citations) and has given 220 national and international invited lectures and has 65 issued or pending patents. Several of his technologies have formed the foundation for products on the market or under development and for the launch of companies including: Gecko Biomedical, Skintifique, Frequency Therapeutics, and Alivio Therapeutics.
The Boston Business Journal recognized Prof. Karp as a Champion in Healthcare Innovation and MIT’s Technology Review Magazine (TR35) recognized him as being one of the top innovators in the world (3 members from his laboratory have received this award). His work has been selected by Popular Mechanic’s “Top 20 New Biotech Breakthroughs that Will Change Medicine.” He gave a TEDMED talk on bioinspired medical innovation and is a member of the TEDMED Editorial Advisory Board. In 2015 he received a Breakthrough Award from the Kenneth Rainin Foundation and was a commencement speaker at the University of Toronto.
Prof. Karp was selected as the Outstanding Faculty Undergraduate Mentor among all Faculty at MIT and he received the HST McMahon Mentoring award for being the top mentor of Harvard-MIT students. To date, 18 trainees from his laboratory have secured faculty positions and many others impactful positions in pharma and biotech industries.